|
Redwood City, CA - January 23, 2007
Genesis Medical Interventional, Inc. proudly announces the commercialization of the novel F.A.S.T. Funnel Catheter Proximal Occlusion and Thrombectomy/Embolectomy Catheter and have initiated delivery of the Funnel Catheter to early adopters of this breakthrough technology.
Results of a multi-institutional clinical trial utilizing the F.A.S.T Funnel Catheter for Proximal Occlusion Embolic Protection were presented at TCT 2006 where the Genesis Medical Funnel Catheter was awarded the TCT 2006 Innovative Therapy. In addition Genesis has received the enthusiastic and overwhelming responses and endorsements of prominent cardiologists and interventionalists because of the effectiveness and ease of use of the device.
"Our first shipments of the F.A.S.T. Funnel Catheter have been to the leading institutions of prominent vascular interventionalists anxious to use our new, breakthrough proximal occlusion catheter. This is an exciting time for Genesis as we begin to realize the fruits of our intensive work for the past few years." says William R. Dubrul, CEO, "Our Funnel Catheter Platform Technology will find many exciting applications as it is put in interventionalists hands."
Genesis will be exhibiting the F.A.S.T Funnel Catheter at the upcoming SIR 2007 in Seattle in early March and ACC 2007 in the end of March in New Orleans, and will provide a "wet lab" demonstrating the instant on/off occlusion feature, intuitive ease of use, the innovative funnel, and other features of the device. A complete description of the F.A.S.T Funnel Catheter can be found at http://www.genesismedical.net/html/products.html or at www.genesismedical.net.
About Genesis Medical Interventional, Inc.
Genesis Medical Interventional, Inc. (Genesis) is a privately held company developing products, based on its minimally invasive Funnel Catheter platform technologies, to remove thrombi and emboli from the vasculature. The company believes its technologies will have applications in many major medical markets. The F.A.S.T. Funnel Catheter has been cleared by the FDA via 510(k) marketing clearance and has a proven track record with over 100 peripheral and coronary clinical cases completed with excellent results.
For additional information, please contact William R. Dubrul, Genesis CEO at will@genesismedical.net or visit the Genesis website at www.genesismedical.net .
This press release contains forward-looking statements that are based upon management's current expectations and are inherently uncertain. Forward-looking statements are based upon information available to us as of the date of this press release and we assume no obligation to revise or update any such forward-looking statement to reflect any event or circumstance after the date of this release. Actual results and timing of events could differ materially from current expectations and from any forward-looking statements made by the company.
|
